ATP6V0A1 and Parkinson disease: Regarding the Atp6v0a1 gene, it was found that the attenuation of the human microglial inflammation and suppression of the expression IL-1 beta and IL-6 by the increase in ATP6V0A1 expression with rifampicin improved the lysosomal function, which may be a novel therapeutic strategy for PD [101].